ICON Group
Browse - Entry Strategy Studies

Home   Email Us   Icon   Partners  
 

Drugs and Pharmaceuticals in Switzerland

Title:

Drugs and Pharmaceuticals in Switzerland: A Strategic Entry Report, 1998

Date Published: 1999-05-03
Pages: 120
ISBN: 0741804646
   
About the Author(s)/Editor(s)
Philip M. Parker
Eli Lilly Chair Professor in Innovation, Business and Society
INSEAD (Fontainebleau, France & Singapore)

Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). He has been a professor there since 1988 where he teaches graduate and doctoral-level courses on global competitive strategy and research methodology. He has taught courses at Harvard University (HBS), the Hong Kong University of Science and Technology, Stanford University (GSB), the Massachusetts Institute of Technology (MIT Sloan School) and UCLA (Anderson School). Dr. Parker received his Ph.D. in Business Economics from the Wharton School at the University of Pennsylvania and has Masters degrees in Finance and Banking (University of Aix-Marseille, France) and Managerial Economics (Wharton). His undergraduate degrees are in mathematics and economics. Some of his work and methodologies applied in this study were financially supported by the Research and Development Committee at INSEAD which is gratefully acknowledged.

About the Series
This series helps international managers expand to various country markets around the world. Each report is a broad study of a particular product market, but also gives information useful for entry strategies (trend analysis, marketing, production, finance, and distribution strategy). Each study provides ample statistics on market size and trends, as well as various economic statistics cover human resources and cross-cultural management.
Contents
1 INTRODUCTION & METHODOLOGY
        1.1 What does this report cover?
        1.2 How to Strategically Evaluate Switzerland
        1.3 Latent Demand and Accessibility in Switzerland
2 DRUGS AND PHARMACEUTICALS
        2.1 Latent Demand and Accessibility: Background
        2.2 Latent Demand: Aspects of Interest
        2.3 accessibility: the structure of competition
        2.3.1 Competitive Factors
        2.3.2 Local Production
        2.3.3 Imports
        2.3.4 End-User Analysis
        2.4 accessibility: key factors
        2.4.1 Import Climate
        2.4.2 Accessibility: Distribution Strategies
        2.5 Key Contacts
        2.5.1 Governmental Issues
        2.5.2 Trade Associations
        2.5.3 Distributors/Wholesalers
        2.5.4 Primary Pharmaceutical Companies
        2.5.5 Best Magazines and Journals for Advertising
        2.5.6 Trade Promotion Opportunities
3 THE ECONOMICS OF LATENT DEMAND IN SWITZERLAND
        3.1 Executive Summary
        3.2 Economic Issues in Switzerland
        3.2.1 Economic Fundamentals and Dynamics
        3.2.2 Principal Growth Sectors
        3.2.3 Manufacturing
        3.2.4 Services
        3.2.5 Agriculture
        3.2.6 Government Role in the Economy
        3.2.7 Trade Balance And Current Account
        3.2.8 Capital Account
        3.2.9 Infrastructure Development
4 EXPORT ACCESSIBILITY IN SWITZERLAND
        4.1 Executive Summary
        4.2 Exporting to Switzerland
        4.2.1 Brief Description of the Banking System
        4.2.2 The Banking Market
        4.2.3 Cantonal Banks
        4.2.4 Big Banks
        4.2.5 Regional And Savings Banks
        4.2.6 Lending Associations
        4.2.7 Other Banks
        4.2.8 Finance Companies
        4.2.9 Private Banks
        4.2.10 Branches Of Foreign Banks
        4.2.11 The Important Role of Foreign Banks
        4.2.12 Specialized Financial Institutions
        4.2.13 Postal Check System
        4.2.14 Swiss Interbank
        4.2.15 Swiss Securities
        4.2.16 Swiss Corporation for International Securities Settlements (Intersettle)
        4.2.17 Swiss Options and Financial Futures Exchange (SOFFEX)
        4.2.18997 Performance of the Banking System
        4.2.19 Recent Developments in Banking Legislation
        4.2.20 Foreign Exchange Controls Affecting Trade
        4.2.21 Availability of Local Financing
        4.2.22 Financing Exports
        4.2.23 Export Financing Options
        4.2.24 Availability of Project Financing
        4.2.25 Trade Barrier Risks
        4.2.26 Agricultural Products
        4.2.27 Food Retailing System
        4.2.28 Swiss Cartels
        4.2.29 Testing and Certification
        4.2.30 Telecommunications
        4.2.31 Customs Duties
        4.2.32 Value Added Tax
        4.2.33 Excise Taxes
        4.2.34 Quotas
        4.2.35 Custom Broker's Fees
        4.2.36 Environmental Taxes
        4.2.37 Import Licenses
        4.2.38 Export Control Issues
        4.2.39 Import/Export Documentation
        4.2.40 Temporary Entry of Imports
        4.2.41 Labeling & Marking Requirements
        4.2.42 Prohibited Imports
        4.2.43 Standards
        4.2.44 Free Trade Zone Options
        4.2.45 Special Import Provisions
        4.2.46 Membership in Free Trade Associations
5 DIRECT INVESTMENT ACCESSIBILITY IN SWITZERLAND
        5.1 Executive Summary: Infrastructure
        5.2 Executive Summary: Natural Resources
        5.3 Executive Summary: Industry
        5.4 Direct Investment in Switzerland
        5.4.1 Openness to Foreign Investment
        5.4.2 Right to Private Ownership and Establishment
        5.4.3 Protection of Property Rights
        5.4.4 Patents
        5.4.5 Copyrights
        5.4.6 Trademarks
        5.4.7 Adequacy Of Laws And Regulation Governing Commercial Transactions
        5.4.8 Foreign Trade Zones / Free Ports
        5.4.9 Performance Requirements/Incentives
        5.4.10 Transparency of the Regulatory System
        5.4.11 Corruption
        5.4.12 Labor
        5.4.13 Efficiency of Capital Markets and Portfolio Investment
        5.4.14 Conversion and Transfer Policies
        5.4.15 Expropriation and Compensation
        5.4.16 Dispute Settlement
        5.4.17 Political Violence
        5.4.18 Bilateral Investment Agreements
        5.4.19 Capital Outflow Policy
6 MARKETING & DISTRIBUTION IN SWITZERLAND
        6.1 Executive Summary
        6.2 Marketing and Distribution in Switzerland
        6.2.1 Distribution and Sales Channels
        6.2.2 Import and Wholesale Trade
        6.2.3 Retail Trade
        6.2.4 Distributors and Agents
        6.2.5 Franchising Activities
        6.2.6 Direct Marketing Options
        6.2.7 Joint Ventures
        6.2.8 Licensing
        6.2.9 Creating a Sales Office
        6.2.10 Selling Strategies
        6.2.11 Print Media
        6.2.12 Radio and TV
        6.2.13 Pricing Issues
        6.2.14 Sales Service/Customer Support
        6.2.15 Public Sector Marketing
        6.2.16 Local Counsel Requirements
        6.2.17 Performing Due Diligence
7 HUMAN RESOURCE ASSESSMENT IN SWITZERLAND
        7.1 Executive Summary
        7.2 Human Resources in Switzerland
        7.2.1 Unionization in Switzerland
        7.2.2 Collective Bargaining in Switzerland
        7.2.3 Workweek and Minimum Wages in Switzerland
        7.2.4 Forced Labor in Switzerland
        7.2.5 Working Ages and Child Labor in Switzerland
8 POLITICAL RISK ASSESSMENT IN SWITZERLAND
        8.1 Executive Summary: Government
        8.2 Executive Summary: Military Organization
        8.3 Democracy in Switzerland
        8.4 Political Issues in Switzerland
        8.4.1 Economic Relationship with the United States
        8.4.2 Major Political Issues Affecting Business Climate
        8.4.3 Brief Synopsis of Political System
9 LEGAL RISK ASSESSMENT IN SWITZERLAND
        9.1 Executive Summary
        9.2 Legal Issues in Switzerland
        9.2.1 Privacy, Search and Seizure
        9.2.2 Trial Justice in Switzerland
        9.2.3 Excessive Punishment in Switzerland
10 CULTURAL AND DEMOGRAPHIC RISKS IN SWITZERLAND
        10.1 Executive Summary
        10.2 Cultural Issues in Switzerland
        10.2.1 Racial, Ethnic and Discrimination Issues in Switzerland
        10.2.2 Women's Rights and Gender Issues in Switzerland
        10.2.3 Religion in Switzerland
        10.2.4 Fundamental Human Rights in Switzerland
11 BUSINESS CUSTOMS IN SWITZERLAND
        11.1 Business Customs
        11.2 Travel Issues
        11.3 Business Infrastructure
        11.4 Temporary Entry Of Goods
 

 

Books from Amazon.Com : Drugs and Pharmaceuticals